niacinamide has been researched along with Lymphoma, T Cell, Peripheral in 1 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibson, JF | 1 |
| Foss, F | 1 |
| Cooper, D | 1 |
| Seropian, S | 1 |
| Irizarry, D | 1 |
| Barbarotta, L | 1 |
| Lansigan, F | 1 |
1 other study available for niacinamide and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Pilot study of sorafenib in relapsed or refractory peripheral and cutaneous T-cell lymphoma.
Topics: Antineoplastic Agents; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Neoplasm R | 2014 |